Process View
Prevention of degradation of mRNA molecules. In the absence of compensating changes in other processes, the slowing of mRNA degradation can result in an overall increase in the population of active mRNA molecules.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "mrna stabilization"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
HNRNPD | heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa) | 1.000 | Rat | |
MAPK14 | mitogen-activated protein kinase 14 | 0.982 | ||
HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | 0.970 | ||
HNRNPF | heterogeneous nuclear ribonucleoprotein F | 0.928 | ||
HNRNPH3 | heterogeneous nuclear ribonucleoprotein H3 (2H9) | 0.913 | ||
HNRNPK | heterogeneous nuclear ribonucleoprotein K | 0.874 | ||
HNRNPA0 | heterogeneous nuclear ribonucleoprotein A0 | 0.826 | Mouse | |
TFDP2 | transcription factor Dp-2 (E2F dimerization partner 2) | 0.805 | ||
IRAK1 | interleukin-1 receptor-associated kinase 1 | 0.784 | ||
PRMT1 | protein arginine methyltransferase 1 | 0.739 | ||
HNRNPR | heterogeneous nuclear ribonucleoprotein R | 0.661 | Human | |
SYNCRIP | synaptotagmin binding, cytoplasmic RNA interacting protein | 0.603 | ||
YBX1 | Y box binding protein 1 | 0.485 | ||
MAPK1 | mitogen-activated protein kinase 1 | 0.444 | ||
HNRNPH1 | heterogeneous nuclear ribonucleoprotein H1 (H) | 0.395 | ||
U2AF2 | U2 small nuclear RNA auxiliary factor 2 | 0.359 | ||
RB1 | retinoblastoma 1 | 0.323 | ||
RBMX | RNA binding motif protein, X-linked | 0.321 | ||
TOP1 | topoisomerase (DNA) I | 0.306 | ||
PTBP1 | polypyrimidine tract binding protein 1 | 0.278 | ||
HNRNPU | heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) | 0.265 | ||
DHX9 | DEAH (Asp-Glu-Ala-His) box polypeptide 9 | 0.205 | ||
ILF3 | interleukin enhancer binding factor 3, 90kDa | 0.178 | ||
RBL2 | retinoblastoma-like 2 (p130) | 0.157 | ||
KHDRBS1 | KH domain containing, RNA binding, signal transduction associated 1 | 0.156 | ||
DUSP1 | dual specificity phosphatase 1 | 0.155 | ||
MAPK6 | mitogen-activated protein kinase 6 | 0.138 | ||
PABPC1 | poly(A) binding protein, cytoplasmic 1 | 0.122 | ||
SUMO3 | SMT3 suppressor of mif two 3 homolog 3 (S. cerevisiae) | 0.112 | ||
E2F2 | E2F transcription factor 2 | 0.104 | Human | |
MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.102 | ||
HNRNPA2B1 | heterogeneous nuclear ribonucleoprotein A2/B1 | 0.101 | ||
HMGA2 | high mobility group AT-hook 2 | 0.101 | ||
RBL1 | retinoblastoma-like 1 (p107) | 0.098 | ||
IRAK2 | interleukin-1 receptor-associated kinase 2 | 0.097 | ||
HSF1 | heat shock transcription factor 1 | 0.096 | ||
TFDP1 | transcription factor Dp-1 | 0.087 | ||
CUX1 | cut-like homeobox 1 | 0.085 | ||
E2F4 | E2F transcription factor 4, p107/p130-binding | 0.078 | Human | |
ELAVL1 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R) | 0.075 | ||
TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.075 | ||
QKI | quaking homolog, KH domain RNA binding (mouse) | 0.068 | Zebrafish | |
AMMECR1 | Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 | 0.067 | ||
HNRPDL | heterogeneous nuclear ribonucleoprotein D-like | 0.066 | ||
TLR4 | toll-like receptor 4 | 0.063 | ||
FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.061 | ||
EIF2C2 | eukaryotic translation initiation factor 2C, 2 | 0.058 | ||
RALY | RNA binding protein, autoantigenic (hnRNP-associated with lethal yellow homolog (mouse)) | 0.058 | Human | |
E2F1 | E2F transcription factor 1 | 0.058 | ||
SFPQ | splicing factor proline/glutamine-rich | 0.056 | ||
PURA | purine-rich element binding protein A | 0.055 | ||
DAZL | deleted in azoospermia-like | 0.055 | ||
FUS | fused in sarcoma | 0.050 | ||
E2F3 | E2F transcription factor 3 | 0.050 | Human | |
NONO | non-POU domain containing, octamer-binding | 0.047 | ||
MYD88 | myeloid differentiation primary response gene (88) | 0.046 | ||
SRSF1 | serine/arginine-rich splicing factor 1 | 0.043 | ||
PHC2 | polyhomeotic homolog 2 (Drosophila) | 0.042 | ||
SF1 | splicing factor 1 | 0.041 | ||
IRAK4 | interleukin-1 receptor-associated kinase 4 | 0.041 | ||
PGF | placental growth factor | 0.035 | ||
RBFOX2 | RNA binding protein, fox-1 homolog (C. elegans) 2 | 0.034 | ||
HNRNPC | heterogeneous nuclear ribonucleoprotein C (C1/C2) | 0.031 | ||
PUM2 | pumilio homolog 2 (Drosophila) | 0.030 | ||
SRSF9 | serine/arginine-rich splicing factor 9 | 0.030 | ||
EIF2AK2 | eukaryotic translation initiation factor 2-alpha kinase 2 | 0.029 | ||
PTBP2 | polypyrimidine tract binding protein 2 | 0.029 | ||
USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.027 | ||
PCBP1 | poly(rC) binding protein 1 | 0.027 | ||
DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.027 | ||
UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.025 | ||
CELF1 | CUGBP, Elav-like family member 1 | 0.025 | ||
HNRNPAB | heterogeneous nuclear ribonucleoprotein A/B | 0.025 | ||
BTG2 | BTG family, member 2 | 0.024 | ||
DDX5 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 | 0.024 | ||
TRA2B | transformer 2 beta homolog (Drosophila) | 0.024 | ||
AHR | aryl hydrocarbon receptor | 0.023 | ||
SNIP1 | Smad nuclear interacting protein 1 | 0.022 | ||
LIN9 | lin-9 homolog (C. elegans) | 0.021 | ||
RBFOX1 | RNA binding protein, fox-1 homolog (C. elegans) 1 | 0.021 | ||
TAB1 | TGF-beta activated kinase 1/MAP3K7 binding protein 1 | 0.021 | ||
CUL3 | cullin 3 | 0.020 | ||
HNRNPA3 | heterogeneous nuclear ribonucleoprotein A3 | 0.019 | ||
GSK3A | glycogen synthase kinase 3 alpha | 0.019 | ||
AEBP2 | AE binding protein 2 | 0.019 | ||
MAX | MYC associated factor X | 0.018 | ||
MAP2K3 | mitogen-activated protein kinase kinase 3 | 0.018 | ||
HDAC11 | histone deacetylase 11 | 0.018 | ||
SAMHD1 | SAM domain and HD domain 1 | 0.018 | ||
DVL1 | dishevelled, dsh homolog 1 (Drosophila) | 0.017 | ||
IGF2BP2 | insulin-like growth factor 2 mRNA binding protein 2 | 0.017 | Human | |
LIN54 | lin-54 homolog (C. elegans) | 0.017 | ||
FBXO33 | F-box protein 33 | 0.017 | ||
MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.016 | ||
ZFP36L1 | zinc finger protein 36, C3H type-like 1 | 0.016 | Human | |
CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | 0.016 | ||
LIMK1 | LIM domain kinase 1 | 0.016 | ||
RBM4 | RNA binding motif protein 4 | 0.015 | ||
BOLL | bol, boule-like (Drosophila) | 0.015 | ||
SF3A1 | splicing factor 3a, subunit 1, 120kDa | 0.015 | ||
MAPK11 | mitogen-activated protein kinase 11 | 0.014 | ||
HNRNPUL1 | heterogeneous nuclear ribonucleoprotein U-like 1 | 0.014 | Human | |
SRSF5 | serine/arginine-rich splicing factor 5 | 0.014 | ||
KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.014 | ||
EFTUD2 | elongation factor Tu GTP binding domain containing 2 | 0.014 | ||
HMGA1 | high mobility group AT-hook 1 | 0.013 | ||
MKNK2 | MAP kinase interacting serine/threonine kinase 2 | 0.013 | ||
EWSR1 | Ewing sarcoma breakpoint region 1 | 0.013 | ||
AXIN1 | axin 1 | 0.013 | Human | |
MAPK3 | mitogen-activated protein kinase 3 | 0.013 | ||
WDR83 | WD repeat domain 83 | 0.013 | ||
HABP4 | hyaluronan binding protein 4 | 0.012 | ||
BHLHE40 | basic helix-loop-helix family, member e40 | 0.012 | ||
TP63 | tumor protein p63 | 0.012 | ||
FOSL2 | FOS-like antigen 2 | 0.012 | ||
MAST1 | microtubule associated serine/threonine kinase 1 | 0.012 | ||
PABPC4 | poly(A) binding protein, cytoplasmic 4 (inducible form) | 0.012 | ||
DUSP7 | dual specificity phosphatase 7 | 0.012 | ||
CDK6 | cyclin-dependent kinase 6 | 0.011 | ||
CNBP | CCHC-type zinc finger, nucleic acid binding protein | 0.011 | ||
CBX6 | chromobox homolog 6 | 0.011 | ||
UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.011 | ||
LMO3 | LIM domain only 3 (rhombotin-like 2) | 0.011 | ||
FRK | fyn-related kinase | 0.011 | ||
NCOA6 | nuclear receptor coactivator 6 | 0.010 |